20th November 2018

Consilium Strategic Communications to Support The Economist Events’ War on Cancer Europe 2018

 

 

LONDON, UK; 20 November 2018, Consilium Strategic Communications, a global leader in strategic healthcare investor relations and communications, will support The Economist Events’ War on Cancer Europe 2018, taking place today at The Waldorf Hilton, Aldwych, London.

Now in its fourth year, War on Cancer Europe 2018, is part of a global series to catalyse fresh debate around strengthening cancer control. The event will bring together clinicians, patients, service providers, industry representatives, employers and policymakers.

 

“We are very pleased to again be supporting the Economist Events’ War on Cancer. Despite significant developments, cancer remains a leading cause of death across Europe and the complexity of navigating treatments and optimising resources has risen to the forefront of public debate."

Mary-Jane Elliott

Managing Partner of Consilium Strategic Communications

“This year’s forum will focus on the technological revolution and the future of patient engagement and how the two can combine to create innovation and improved patient experiences. We are very much looking forward to the event, the panels and the lively discussions it will provoke."

Mary-Jane Elliott

Managing Partner of Consilium Strategic Communications

-Ends-

For more information and to view the full programme please visit: www.waroncancereurope.economist.com

 

Follow the War on Cancer summit via @EconomistEvents #WaronCancer on Twitter to get the latest updates, submit your questions, and join in with discussions on the day.

For more information please contact:

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner

Tel: +44(0)20 3709 5700

info@consilium-comms.com/

www.consilium-comms.com

Follow us: @consiliumhc

 

About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.

 

About War on Cancer 2018:

Despite significant strides in prevention and in survivorship, cancer remains a leading cause of death across Europe. With nearly 200 variations of cancer, the complexity of navigating treatments and optimising resources has risen to the forefront of public debate. Technological innovations--from AI, to wearables, to advancements in immunotherapy, to CAR-T and radiotherapy treatments, are rapidly redefining patient experiences.

As the digital revolution accelerates, the opportunities for patients to take ownership of their diagnosis, treatments and oncology journey have grown. How will current data privacy laws such as GDPR impact patient treatments? How can stakeholders work collaboratively to ensure patient engagement is more than a moral imperative but a tool for driving progress in oncology care? Will increased patient access to data strengthen relationships with clinicians or create new tensions for care? What can be learned from regions in Europe like the Nordics, that are taking the lead on meaningful patient collaboration and engagement with emerging technologies? How can patient engagement strengthen drug discovery, R&D and regulation?


Back to previous page